NCT04398329 - Dose-Escalation Study of HTX-034 Following Bunionectomy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

August 3, 2021

Conditions

Bunions

Interventions

DRUG

HTX-034

HTX-034, low dose

DRUG

HTX-034

HTX-034, high dose

DEVICE

Luer lock applicator

Applicator for instillation

DRUG

Bupivacaine HCl

Bupivacaine HCl, 50 mg

Trial Locations (4)

First Surgical Hospital, Bellaire

Endeavor Clinical Trials, LLC, San Antonio

JBR Clinical Research, Salt Lake City

Arizona Research Center, Phoenix